Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

The Lancet

Topics

Finance

Pathology

Economics

Finance

Medicine

Pathology

Business

Show all topics

DOI

10.1016/s0140-6736(15)00469-9

Other Formats

PDF